BPC-157 20mg + TB-500 20mg Research Bundle

Description

This research bundle contains 20mg of BPC-157 and 20mg of TB-500, supplied across eight separate 5mg vials. The compounds are not blended or premixed, allowing each material to remain individually contained and identifiable for laboratory research.

Each bundle contains:

• 4 × BPC-157 5mg vials — 20mg total
• 4 × TB-500 5mg vials — 20mg total
• 8 vials total
• Total nominal peptide content: 40mg

Both compounds are supplied as lyophilised powders for laboratory research and analytical applications.

Technical Specifications

BPC-157

Product Name: BPC-157
CAS Number: 137525-51-0
Molecular Formula: C₆₂H₉₈N₁₆O₂₂
Molecular Weight: 1419.54 g/mol
Sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val
Form: Lyophilised Powder
Individual Vial Content: 5mg
Quantity: 4 vials
Total Content: 20mg

TB-500

Product Name: TB-500
CAS Number: 885340-08-9*
Form: Lyophilised Powder
Individual Vial Content: 5mg
Quantity: 4 vials
Total Content: 20mg

TB-500 naming and chemical identifiers can vary depending on the specific peptide material supplied. The applicable CAS number, sequence and molecular specifications should therefore be verified against the relevant supplier or batch documentation before publication.

Quality & Batch Testing

Axium products are sourced with an emphasis on compound identity, consistency and documented quality.

Where applicable, batch-specific analytical documentation, including High-Performance Liquid Chromatography (HPLC) testing, is made available to provide researchers with additional information regarding the materials supplied.

As BPC-157 and TB-500 are supplied in separate vials, applicable analytical documentation should be referenced against the individual compound and production batch.

Storage & Handling

Both lyophilised materials should be stored under appropriate laboratory conditions, protected from direct light, moisture and unnecessary temperature fluctuations.

For longer-term storage, follow the conditions specified within the relevant supplier or batch documentation. Each compound should be handled separately using established laboratory procedures appropriate to the material.

UK Stock & Dispatch

Axium products are stocked and dispatched from within the United Kingdom, allowing orders to be processed without international fulfilment delays.

Typical dispatch time: 1–2 working days.

Research Use Only

For laboratory research purposes only. Not for human or veterinary use.

BPC-157 and TB-500 supplied by Axium are intended solely for qualified laboratory research and analytical applications. They are not supplied for consumption, diagnostic, therapeutic or other clinical applications.

Frequently Asked Questions

Are BPC-157 and TB-500 mixed together?
No. The compounds are supplied separately. The bundle contains four 5mg vials of BPC-157 and four 5mg vials of TB-500. The compounds are not blended or premixed.

What does the bundle contain?
Each bundle contains 4 × BPC-157 5mg vials (20mg total) and 4 × TB-500 5mg vials (20mg total), supplied separately.

What is the total peptide content?
The eight individual vials provide a combined nominal peptide content of 40mg — 20mg BPC-157 and 20mg TB-500.

Why is each 20mg quantity supplied as four 5mg vials?
BPC-157 and TB-500 are supplied in individual 5mg vial sizes, meaning each 20mg quantity is provided as 4 × 5mg vials.

Is batch testing available?
Analytical documentation may be available for specific production batches. Refer to the relevant batch documentation for each individual compound.

Where is the bundle dispatched from?
Orders are dispatched from UK-held stock, with typical dispatch within 1–2 working days.

What is this product sold for?
Both compounds are supplied exclusively for laboratory research purposes and are not for human or veterinary use.